REMEGEN CO LTD-H (REGMF:OTCMKTS)
$10.9491 0.9491 (9.491%)
Analysed REMEGEN CO LTD-H (REGMF:OTCMKTS) News Sources
Generalized Myasthenia Gravis Market on the Brink of Change: 8 Promising Late-Stage Drugs Signal a New Treatment Era | DelveInsight
15-04-2026
yahoo.com
3 Asian Growth Companies With High Insider Ownership Growing Revenues Up To 24%
31-03-2026
yahoo.com
Vertex Pops On 'Remarkable' Results For Chronic Kidney Disease Drug
10-03-2026
yahoo.com
Asian Market Picks: Mao Geping Cosmetics And 2 Other Stocks That May Be Priced Below Their Estimated Value
11-02-2026
yahoo.com
3 Asian Stocks That May Be Undervalued By Up To 41.4%
06-01-2026
yahoo.com
Asian Growth Companies With High Insider Ownership In January 2026
05-01-2026
yahoo.com
Asian Market Value Picks Featuring 3 Stocks Trading Below Estimated Worth
28-11-2025
yahoo.com
Asian Growth Companies With Strong Insider Confidence November 2025
20-11-2025
yahoo.com
Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China
08-11-2025
yahoo.com
3 Asian Stocks That May Be Trading Below Their Estimated Intrinsic Value
30-10-2025
yahoo.com
What is the current price of REMEGEN CO LTD-H (REGMF:OTCMKTS)?
The current price of REMEGEN CO LTD-H (REGMF:OTCMKTS) is $10.9491.
REMEGEN CO LTD-H (REGMF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of REMEGEN CO LTD-H (REGMF:OTCMKTS) since the previous trading day is $0.9491.
REMEGEN CO LTD-H (REGMF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of REMEGEN CO LTD-H (REGMF:OTCMKTS) since the previous trading day is 9.491%.
What is the most recent average sentiment score for REMEGEN CO LTD-H (REGMF:OTCMKTS)?
The most recent average sentiment score for REMEGEN CO LTD-H (REGMF:OTCMKTS) is 75 out of 100.
What is the most recent average sentiment for REMEGEN CO LTD-H (REGMF:OTCMKTS)?
The most recent sentiment for REMEGEN CO LTD-H (REGMF:OTCMKTS) is .
SEC-8K** Filing Available For REMEGEN CO LTD-H (REGMF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.